Stock analysis for Puma Biotechnology Inc (PBYI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. PBYI -- Is Its Stock Price A Worthy Investment? Learn More. PBYI Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for PBYI is 15.59 -- better than 98.18% of US stocks. Equity multiplier, or assets relative to shareholders' equity, comes in at 10.39 for Puma Biotechnology Inc; that's greater than it is for 93.78% of US stocks. Earnings Whisper Number for PBYI: Puma Biotechnology Aug 08, 2019 · Puma Biotechnology (PBYI) reports earnings on 5/21/2020. Shares are down 33.8% since reporting last quarter. The Earnings Whisper Score gives the …
Check PBYI stock rating before trading Puma Biotechnology Inc
http://finance.yahoo.com/q/ks?s=PBYI+Key+Statistics Puma Biotechnology, Inc., a development-stage biopharmaceutical company, engages in the acquisition, (NASDAQ:PBYI) will be pleased this week, given that the stock price is up 11 Yahoo Finance · Feb 23 · Edited Transcript of PBYI earnings conference call or Puma Biotechnology Inc (PBYI): Price and Financial Metrics Stocks that are quantitatively similar to PBYI, based on their financial statements, market Puma Biotechnology Inc (PBYI) Stock Quote, History and News - Yahoo Finance 17 Jan 2020 On 11/19/2019, the institutional investor purchased 1,2 million stock rights in a trade. THE VANGUARD GROUP, INC executed another new PBYI - Short squeeze stock short interest data and short selling information for Short interest stock data available for NASDAQ, NYSE, AMEX, OTCBB and Pink short last month, according to ShortSqueeze.com. - Reuters / Yahoo! Finance
Despite the earnings and sales beat, the stock was down 10.3% in after-hours trading on Thursday probably due to the poor guidance for the first quarter of 2020. The stock has declined 47.6% in the past year compared with the industry’s decrease of 1.8%.
prices, M&A, institutional ownership, analyst reports and stock quotes - FT.com. Puma Biotechnology IncPBYI:NSQ, 6.51%, 2.54m+9,534.42%, 27.28m USD. Stock Market Today acts as a temperature check on the markets, identifying the trends that affect Wall Street on down through Main Street. Whether it's a new IPO Puma Biotechnology Inc (PBYI) Stock Price, Quote ... - Yahoo Find the latest Puma Biotechnology Inc (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing. PBYI Interactive Stock Chart | Puma Biotechnology, Inc ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Aug 08, 2019 · Puma Biotechnology (PBYI) reports earnings on 5/21/2020. Shares are down 33.8% since reporting last quarter. The Earnings Whisper Score gives the …
View the latest PBYI stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of PUMA BIOTECHNOLOGY, INC.. PBYI Puma Biotechnology Inc. — Stock Price and Discussion ... Apr 03, 2020 · Real-time trade and investing ideas on Puma Biotechnology Inc. PBYI from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Puma Biotechnology Inc Common Stock (PBYI) After-Hours ... Puma Biotechnology Inc Common Stock (PBYI) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Puma Biotechnology Inc Stock Quote: PBYI Stock News ... Nov 04, 2019 · PBYI, Puma Biotechnology Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Puma Biotechnology Inc's stock rating is based on fundamental analysis. Don't miss PBYI stock next rating changes
View Puma Biotechnology, Inc.'s fair value, margin of safety, stock price, financial statements, news, valuation models, 21 days agofinance.yahoo.comPBYI http://finance.yahoo.com/q/ks?s=PBYI+Key+Statistics Puma Biotechnology, Inc., a development-stage biopharmaceutical company, engages in the acquisition,